AR002742A1 - Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn - Google Patents
Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adnInfo
- Publication number
- AR002742A1 AR002742A1 ARP960102592A AR10259296A AR002742A1 AR 002742 A1 AR002742 A1 AR 002742A1 AR P960102592 A ARP960102592 A AR P960102592A AR 10259296 A AR10259296 A AR 10259296A AR 002742 A1 AR002742 A1 AR 002742A1
- Authority
- AR
- Argentina
- Prior art keywords
- protein
- codes
- vector
- procedure
- produce
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Se trata de una proteina útil para regular el tejido adiposo y por lo tanto de utilidad para el tratamiento de estados de obesidad. Dicha proteinatiene la secuencia: SEC ID Ns 1; donde Xaa tiene los valores indicados en la descripción.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44530595A | 1995-05-19 | 1995-05-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002742A1 true AR002742A1 (es) | 1998-04-29 |
Family
ID=23768399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960102592A AR002742A1 (es) | 1995-05-19 | 1996-05-16 | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0743321A3 (es) |
JP (1) | JPH11505706A (es) |
AR (1) | AR002742A1 (es) |
AU (1) | AU5795496A (es) |
CA (1) | CA2221303A1 (es) |
IL (1) | IL118297A0 (es) |
PE (1) | PE50997A1 (es) |
WO (1) | WO1996036644A1 (es) |
YU (1) | YU29596A (es) |
ZA (1) | ZA963915B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048837A (en) * | 1994-08-17 | 2000-04-11 | The Rockefeller University | OB polypeptides as modulators of body weight |
US6429290B1 (en) | 1994-08-17 | 2002-08-06 | The Rockefeller University | OB polypeptides, modified forms and derivatives |
US6471956B1 (en) | 1994-08-17 | 2002-10-29 | The Rockefeller University | Ob polypeptides, modified forms and compositions thereto |
US6124448A (en) * | 1994-08-17 | 2000-09-26 | The Rockfeller University | Nucleic acid primers and probes for the mammalian OB gene |
US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
US6350730B1 (en) | 1994-08-17 | 2002-02-26 | The Rockefeller University | OB polypeptides and modified forms as modulators of body weight |
US6225446B1 (en) | 1995-12-06 | 2001-05-01 | Schering Corporation | Mutational variants of mammalian proteins |
AU1406497A (en) * | 1995-12-06 | 1997-06-27 | Schering Corporation | Mutational variants of mammalian ob gene proteins |
JP2000504319A (ja) * | 1996-01-19 | 2000-04-11 | イーライ・リリー・アンド・カンパニー | 肥満症タンパク質製剤 |
AU2246097A (en) * | 1996-01-25 | 1997-08-20 | Eli Lilly And Company | Obesity protein analog compounds and formulations thereof |
US6001816A (en) * | 1996-06-20 | 1999-12-14 | Merck & Co., Inc. | Gene therapy for leptin deficiency |
US6277592B1 (en) * | 1996-07-31 | 2001-08-21 | Purina Mills, Inc. | Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof |
US20020110857A1 (en) * | 1996-07-31 | 2002-08-15 | Spurlock Michael E. | Bovine leptin protein, antisense and antibody |
US6297027B1 (en) * | 1996-07-31 | 2001-10-02 | Purina Mills, Inc. | Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof |
US5965521A (en) * | 1997-02-25 | 1999-10-12 | Eli Lilly Company | Pulsatile delivery of leptin receptor ligands |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
CA2211664A1 (en) * | 1995-01-31 | 1996-08-08 | Eli Lilly And Company | Anti-obesity proteins |
-
1996
- 1996-05-16 AR ARP960102592A patent/AR002742A1/es unknown
- 1996-05-16 JP JP8535053A patent/JPH11505706A/ja active Pending
- 1996-05-16 EP EP96303478A patent/EP0743321A3/en not_active Withdrawn
- 1996-05-16 WO PCT/US1996/007045 patent/WO1996036644A1/en active Search and Examination
- 1996-05-16 IL IL11829796A patent/IL118297A0/xx unknown
- 1996-05-16 PE PE1996000338A patent/PE50997A1/es not_active Application Discontinuation
- 1996-05-16 AU AU57954/96A patent/AU5795496A/en not_active Abandoned
- 1996-05-16 ZA ZA9603915A patent/ZA963915B/xx unknown
- 1996-05-16 YU YU29596A patent/YU29596A/sh unknown
- 1996-05-16 CA CA002221303A patent/CA2221303A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU5795496A (en) | 1996-11-29 |
PE50997A1 (es) | 1997-12-18 |
ZA963915B (en) | 1997-11-17 |
EP0743321A3 (en) | 1997-01-15 |
WO1996036644A1 (en) | 1996-11-21 |
CA2221303A1 (en) | 1996-11-21 |
JPH11505706A (ja) | 1999-05-25 |
YU29596A (sh) | 1998-07-10 |
IL118297A0 (en) | 1996-09-12 |
EP0743321A2 (en) | 1996-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
BR0213786A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
HUP0204199A2 (hu) | Transzport vektorok | |
DE3880739D1 (de) | Expression von menschlichem proapolipoprotein a-1. | |
DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
DE60032486D1 (de) | Prion protein peptide und deren verwendung | |
AR005940A1 (es) | Composicion cosmetica de fijacion y brillo en aerosol, y procedimiento | |
AR008765A1 (es) | Un peptido o un derivado, analogo o variante, funcional del mismo, un peptido recombinante o sintetico del mismo, una secuencia nucleotidica y vectorque la contiene, una celula huesped transformada, un procedimiento para su preparacion, una composicion farmaceutica que lo comprende, un compuesto del | |
ES2061520T3 (es) | Expresion de un antigeno especifico de tumor por un virus vector recombinante y utilizacion de este para el tratamiento preventivo o curativo del tumor correspondiente. | |
PE20010694A1 (es) | Plasmido autonomamente reproducible en bacterias corineformes | |
AR013529A1 (es) | Rantes amino-terminalmente truncado, moleculas de adn, vector de expresion, celula huesped, proceso recombinante para prepararlo, su uso para preparar un medicamento y composicion farmaceutica que lo comprende. | |
BR0209990A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
DE69839566D1 (de) | Chimäre polypeptide, die das fragment b des shigatoxins sowie peptide von therapeutischem interesse enthalten | |
BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
ES2146214T3 (es) | Vacunas para actinobacillus pleuropneumoniae. | |
BR9710975A (pt) | Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis | |
YU75600A (sh) | Upotreba polipeptida faktora transkripcije e | |
ATE211765T1 (de) | Neue familie von proteaseinhibitoren und andere biologisch aktive substanzen | |
EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
ATE310828T1 (de) | Implantat und vektor zur behandlung von erworbenen krankheiten | |
CO4480058A1 (es) | Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa | |
ES2176334T3 (es) | El uso de gabapentin en el tratamiento de la ansiedad y el panico. | |
PT870015E (pt) | Novas xilanases os genes que as codificam e as suas utilizacoes | |
ES2097368T3 (es) | Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres. | |
ATE293163T1 (de) | Cyclin e spezifische konstrukte und komplexe |